BIO Investor Forum
Michael O’Donnell is a panelist at the 2014 BIO Investor Forum held in San Francisco.
His session will discuss how the recent expansion and acceleration of the biotech stock market has seen a new willingness and in some cases eagerness to pursue crossover investing in firms pre- and post-IPO. Venture capitalists have become less dogmatic about funding stage and equity share when positive returns seem nearly guaranteed and investment banks are engaging in discussions with entrepreneurs earlier than ever. Relatedly, corporate venture capital executives’ missions have broadened to consider more diverse forms of collaboration than the path to full acquisition. This panel will discuss how temporary or permanent these shifts appear to be and the implications for biotech firms reaching out to the investment community.